ABOUT US

Since the early 1990s, our research group has been actively engaged in the fields of Optoelectronics and Photonics, with a primary focus on the design and development of photonics-based sensing devices and probes for applications ranging from healthcare and biomedical diagnostics to environmental monitoring. 

A distinctive strength of the group is its highly multidisciplinary composition, bringing together researchers with expertise in Physics, Engineering, Chemistry, Pharmaceutical Chemistry and Technology, Biotechnology, Statistics, and Data Science. This broad scientific background enables the team to address the complex challenges of biophotonic diagnostics through an integrated and comprehensive approach. 

Over the past fifteen years, the group's research activities have focused on invasive and minimally invasive sensing technologies, the development of Point-of-Care Testing (POCT) devices, and the design of optical nanoprobes for intracellular sensing and cancer theranostics. Major research achievements include DNA-based platforms for NF-κB detection, optical biochips for immunosensing applications, and the development, fabrication, and clinical validation of optical fiber sensors for the continuous monitoring of gastric carbon dioxide, bile, and interstitial pH. 

The group has also pioneered molecular beacon-based technologies for the detection of circulating microRNAs and their use as intracellular theranostic tools. Research efforts have been also directed toward the translation of photonic technologies into clinical practice through the development of POCT systems for the detection of sepsis biomarkers and devices for the continuous monitoring of immunosuppressive drugs in transplant recipients.

Through the combination of expertise in photonics, nanotechnology, molecular diagnostics, and clinical translation, the group continues to develop innovative sensing solutions aimed at advancing precision medicine and improving patient care.